585 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Acquired by Alpine Bank Wealth Management

Alpine Bank Wealth Management bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 1st quarter, HoldingsChannel reports. The fund bought 585 shares of the financial services provider’s stock, valued at approximately $75,000.

Several other institutional investors also recently bought and sold shares of IBB. Golden State Wealth Management LLC raised its stake in iShares Biotechnology ETF by 97.7% in the first quarter. Golden State Wealth Management LLC now owns 1,916 shares of the financial services provider’s stock valued at $245,000 after buying an additional 947 shares during the last quarter. Global Assets Advisory LLC increased its holdings in shares of iShares Biotechnology ETF by 255.6% during the first quarter. Global Assets Advisory LLC now owns 7,315 shares of the financial services provider’s stock valued at $866,000 after acquiring an additional 5,258 shares in the last quarter. Mascagni Wealth Management Inc. increased its holdings in shares of iShares Biotechnology ETF by 18.4% during the first quarter. Mascagni Wealth Management Inc. now owns 1,918 shares of the financial services provider’s stock valued at $254,000 after acquiring an additional 298 shares in the last quarter. Eagle Strategies LLC raised its position in shares of iShares Biotechnology ETF by 10.2% in the 1st quarter. Eagle Strategies LLC now owns 12,800 shares of the financial services provider’s stock valued at $1,637,000 after purchasing an additional 1,181 shares during the last quarter. Finally, Valmark Advisers Inc. raised its position in shares of iShares Biotechnology ETF by 57.8% in the 1st quarter. Valmark Advisers Inc. now owns 2,434 shares of the financial services provider’s stock valued at $311,000 after purchasing an additional 892 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $126.69 on Thursday. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $150.57. The company’s 50 day moving average is $123.39 and its two-hundred day moving average is $129.66.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.